SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-070229
Filing Date
2023-03-14
Accepted
2023-03-14 17:04:30
Documents
13
Period of Report
2023-03-14
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d469259d8k.htm   iXBRL 8-K 23410
5 GRAPHIC g469259g0314231410813.jpg GRAPHIC 2872
  Complete submission text file 0001193125-23-070229.txt   149528

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nvta-20230314.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20230314_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20230314_pre.xml EX-101.PRE 10813
7 EXTRACTED XBRL INSTANCE DOCUMENT d469259d8k_htm.xml XML 3267
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 23731873
SIC: 8071 Services-Medical Laboratories